secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLARIVATE PLC (CLVT)
CIK:        0001764046
Form:       8-K
Filed at:   2026-07-29T10:03:16+00:00
Accession:  0001764046-26-000090
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clarivate Q2 revenue down 5.5% to $587M; net loss $269M on goodwill impairment; reaffirms FY outlook
--------------------------------------------------------------------------------

- Q2 total revenues $587.3M, down 5.5% YoY; organic revenue -1.5% as subscription +0.7% offset by transactional -15.7%.
- Net loss $268.6M ($0.42 diluted EPS) vs $72.0M loss in Q2 2025, driven by $221.7M non-cash goodwill impairment.
- Adjusted net income $123.1M ($0.19 diluted EPS) vs $123.3M ($0.18) in Q2 2025; adjusted EBITDA $247.2M vs $261.6M.
- First-half 2026 free cash flow $122.9M vs $160.6M prior year; debt reduced by $218.4M including $100M accelerated repayment.
- Reaffirms full-year 2026 outlook; previously announced Life Sciences & Healthcare segment divestiture ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764046/000176404626000090/0001764046-26-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764046/000176404626000090/clvt-20260729.htm
  HTML page:      https://secwatch.observer/filing/0001764046-26-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer